About the Customer
Global Biopharma Footprint: A premier global pharmaceutical and biotech conglomerate manufacturing advanced biopharmaceuticals, biologics, and small-molecule APIs.
Market Dominance: The world's largest commercial producer of sulfamethoxazole APIs and a leading producer of high-volume generic therapeutics serving regulated life sciences markets worldwide.
Enterprise Scale: Fully US-FDA compliant and WHO-GMP certified across its manufacturing matrix, generating over $600M+ in annual revenue.
Deployment Overview
Targeted Implementation: Deployed at the group's flagship high-volume API manufacturing facility across two core production lines.
Digital Overlay Matrix: In continuous production, Litewave operates as a non-invasive digital layer directly over legacy paper-based batch records, requiring zero structural infrastructure changes or electronic Batch Production Record (eBPR) software overhauls.
Resource Scaling: Faced with site capacity expansion, the facility leveraged Litewave's Customer-Specific AI Quality Agents to augment their existing QA team, scaling operational throughput and breaking documentation bottlenecks without a corresponding increase in headcount.
The Problem: Hurdles in Quality & Operations
The manual environment at the facility faced three systemic challenges.
1. Data Discoverability & "Dark Data"
Information trapped in silos made PQR and APQR reporting a labor-intensive manual exercise, often delaying critical compliance insights.
2. Manual Batch Disposition Bottlenecks
- •Operating scale & complexity: high documentation volume led to significant reviewer fatigue.
- •"Needle in a haystack": spotting quality issues in 100–150 page paper records was inefficient and error-prone.
- •Consistency & traceability: heavy manual workflows challenged consistency, and traceability issues tied directly back to manual process limitations.
- •Siloed deviation institutional knowledge: reviewers lacked immediate access to historical resolution data, forcing quality agents to investigate recurring anomalies entirely from scratch rather than leveraging past resolution insights to accelerate disposition velocity.
3. Identifying Key Yield Performance Drivers
Yield often varied within "acceptable" ranges, but the lack of integrated data made it impossible to identify the underlying drivers of these concerning fluctuations.
The Litewave Solution: AI-Powered Data Foundation
Litewave uses a Data Fabric architecture and Quality Intelligence layer to deliver value across three pillars.
Digitization
- HPLC records & chromatograms
- BPRs & worksheets
- Analytical Test Records (ATRs)
Quality Intelligence
- Automated release checklists
- Customer-Specific AI Quality Agents
- Golden Batch yield optimization
Compliance
- Embedded ALCOA+ controls
- Continuous audit readiness
- Searchable digital trails
Value Realized
- •Speed: hands-on batch review compressed from days to hours, cutting overall batch disposition time by 85%.
- •Efficiency: improved batch yield efficiency through performance driver identification.
- •Preparedness: eliminated manual assembly for audits; a consistent state of readiness.
- •Compounding Speed: leveraged historical deviation intelligence to proactively compress future investigation cycles and ensure rapid batch disposition.
Batch Disposition: Before and After
We were initially unsure how AI could meet strict regulatory demands, but Litewave delivered auditable insights in just days… our team is now always audit-ready without the manual overhead.